[
  {
    "header": "General Queries",
    "item": 1001,
    "questionList": [
      {
        "questionIndex": "1",
        "question": "Who decides whether the patient can participate in the PBP Program?",
        "answer": "The patientâ€™s ability to participate in the PBP Program is entirely dependent on the prescribing decision made by the treating Oncologist."
      },
      {
        "questionIndex": "2",
        "question": "Who decides whether the patient's treatment is working or not?",
        "answer": "Any decision regarding the success/failure of your treatment will be made by your Oncologist and we will consider their decision to be final."
      },
      {
        "questionIndex": "3",
        "question": "What is the success rate of the targeted therapy drug prescribed to the patient?",
        "answer": "As is the case in any healthcare treatment, the success rate of a drug depends on several factors such as age, cancer stage/grade, patient health, and so on. We recommend you consult your Oncologist to better understand the success rate of your prescribed drug, as well as the clinical endpoint defined for the treatment."
      },
      {
        "questionIndex": "4",
        "question": "What costs are covered by the PBP Programme? Drugs? Hospital expenses? Travel expenses? Tests?",
        "answer": "Currently, the PBP Program only covers the costs for your targeted therapy drugs. Hospitalisation costs, doctor's fees, lab/diagnostic test expenses, etc. are not covered under the Program."
      },
      {
        "questionIndex": "5",
        "question": "What if my application is unsuccessful during credit assessment?",
        "answer": "Mango Cancer Care will check with all our lending partners regarding your eligibility requirements and specific credit assessments. If your application is rejected, you will be informed, and the patient will cant assign another applicant to apply for credit assessment on their behalf."
      },
      {
        "questionIndex": "6",
        "question": "What is the loan interest rate that I will have to pay? What is the tenure/timeline of the loan?",
        "answer": "In order to promote the affordability of novel cancer therapies, we are working with our lending partners to ensure low effective interest rates on loans. These interest rates will be at the sole discretion of our lending partners, while the timelines and tenure of the loan may vary according to the price of each drug. Further details will be provided to you at the time of application."
      },
      {
        "questionIndex": "7",
        "question": "What if the patient decides to drop out of the Program mid-way?",
        "answer": "If the patient decides to drop out of the Program mid-way due to a non-clinical reason(s), you will not be eligible for any value-based discounts. If, however, the treating Oncologist decides to stop the treatment due to a clinical reason, you will then be eligible for a predetermined discount on the cost of the drug as defined before the onset of the Program."
      },
      {
        "questionIndex": "8",
        "question": "How much loan payment will I have to make if the treatment fails, or if the treatment succeeds?",
        "answer": "Based on the clinical endpoint and duration of treatment defined by the treating Oncologist for a specific indication and drug combination, a predetermined schedule and discounting regimen will be devised by Mango Cancer Care, for you. All payments and discounts will be governed by this schedule for the entirety of the PBP Program."
      }
    ]
  },

  {
    "header": "Additional Information",
    "item": 1005,
    "questionList": [
      {
        "questionIndex": "12",
        "question": "Where can I find more information about targeted cancer therapies and other knowledge resources?",
        "answer": "You can log in to Mango's Querent PBP App to get access to various resources related to targeted cancer therapy. Alternatively, you can also speak to your healthcare advisor regarding any additional print resources available for your reference."
      }
    ]
  }
]
